Ardent Health (ARDT) Expected to Announce Quarterly Earnings on Wednesday

Ardent Health (NYSE:ARDT) is expected to issue its Q3 2026 results after the market closes on Wednesday, November 4th. Analysts expect Ardent Health to announce earnings of $0.2320 per share and revenue of $1.60 billion for the quarter. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. Investors can find conference call details on the company’s upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Thursday, November 5, 2026 at 10:00 AM ET.

Ardent Health (NYSE:ARDT) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.12 earnings per share for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.06). Ardent Health had a net margin of 1.22% and a return on equity of 10.35%. The firm had revenue of $1.62 billion during the quarter, compared to analysts’ expectations of $1.59 billion. On average, analysts expect Ardent Health to post $0.96 EPS for the current fiscal year and $1.20 EPS for the next fiscal year.

Ardent Health Trading Down 2.3%

Ardent Health stock traded down $0.28 during midday trading on Monday, hitting $11.75. 15,340 shares of the stock were exchanged, compared to its average volume of 450,852. The stock has a market capitalization of $1.66 billion, a price-to-earnings ratio of 21.37, a PEG ratio of 3.41 and a beta of 0.72. The company has a current ratio of 2.10, a quick ratio of 1.99 and a debt-to-equity ratio of 0.61. Ardent Health has a fifty-two week low of $7.71 and a fifty-two week high of $14.99. The stock’s 50-day simple moving average is $11.16 and its 200 day simple moving average is $9.97.

Analysts Set New Price Targets

Several brokerages have recently weighed in on ARDT. Weiss Ratings raised Ardent Health from a “sell (d)” rating to a “sell (d+)” rating in a report on Tuesday, October 6th. Royal Bank Of Canada boosted their price objective on shares of Ardent Health from $12.00 to $13.00 and gave the stock an “outperform” rating in a report on Monday, August 10th. The Goldman Sachs Group reiterated a “neutral” rating and issued a $13.00 price objective on shares of Ardent Health in a research report on Thursday, August 6th. Zacks Research raised Ardent Health from a “strong sell” rating to a “hold” rating in a research report on Monday, September 7th. Finally, Wall Street Zen lowered Ardent Health from a “buy” rating to a “hold” rating in a research report on Sunday, July 12th. Seven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $12.79.

About Ardent Health

Ardent Health is a U.S. healthcare services company that operates hospitals, outpatient facilities and physician practices. Its services include emergency and acute care, surgery, cardiology, orthopedics, oncology, women’s health, behavioral health, rehabilitation, imaging and other specialty and primary care offerings.

The company serves patients through regional health networks and hospital campuses primarily in Texas, Oklahoma, New Mexico and other U.S. markets. In addition to hospital-based care, Ardent operates outpatient clinics, urgent care locations and other facilities designed to provide services across different stages of the patient-care process.

Ardent Health was founded in 2001 and became a publicly traded company on the New York Stock Exchange in 2024.